DJIA 16,501.65 0.00 0.00%
NASDAQ 4,126.97 0.00 0.00%
S&P 500 1,875.39 0.00 0.00%
market minute promo

Dendreon Corp

NASDAQ: DNDN

2.67 0.00 (0.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

DNDN $2.67 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.69
Previous Close $2.67
Daily Range $2.66 - $2.73
52-Week Range $2.23 - $5.38
Market Cap $424.5M
P/E Ratio -1.37
Dividend (Yield) $0.00 (0.0%)
Volume 1,791,695
Average Daily Volume 2,713,366
Current FY EPS -$0.88

Sector

Healthcare

Industry

Drugs

Dendreon Corp (DNDN) Description

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Website: http://www.dendreon.com/

News & Commentary

These 5 Cancer Immunotherapy Companies All Have 1 Thing in Common

Cancer immunotherapies are all the rage on Wall Street, but these five immunotherapy-focused companies all have one big thing in common.

Companies Betting on the Next 10 Blockbuster Drugs

Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats Street View

Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats Street View

Dendreon Says Prelim. Data from LT Phase II STAND Study Will Be Presented at EAU Congress, Will Show

Dendreon Says Prelim. Data from LT Phase II STAND Study Will Be Presented at EAU Congress, Will Show Immune Responses with PROVENGE Enhanced, Sustained

Who Bucked the Short Interest Trend in Biotech Stocks?

Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

8 Biotech Events To Anticipate This Year: Part Two

Short Sellers Find Renewed Interest in Biotech Stocks

Dendreon Ready For A Rebound

3 Reasons To Buy Dendreon

See More DNDN News...

DNDN's Top Competitors

DNDN $2.67 (0.00%)
Current stock: DNDN
AMGN $113.91 (0.53%)
Current stock: AMGN
GILD $74.28 (0.57%)
Current stock: GILD
BIIB $306.06 (-0.22%)
Current stock: BIIB